World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
9475
World Ranking
14047
National Ranking
5924

Martin D. McCarter publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Martin D. McCarter sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 429 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Martin D. McCarter D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Martin D. McCarter sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Martin D. McCarter is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily spans the field of Medicine with a focus on Oncology, Surgery, Pulmonary and Respiratory Medicine, Immunology, and Molecular Biology. Within these fields, their work addresses various aspects of cancer and immunotherapy.

The scientist's main topics of research include:

  • Cancer Immunotherapy and Biomarkers
  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics

Among recent publications, several key papers include:

  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021 (2020), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022 (2022), Journal of the National Comprehensive Cancer Network
  • Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling (2021), Immunobiology
  • Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy (2020), Cancers

Frequent co-authors collaborating with Martin D. McCarter include Michelle L. Churchman, Ahmad A. Tarhini, Ana Gleisner, Richard P. Tobin, and Aik Choon Tan.

Their work has appeared extensively in a number of publication venues, notably:

  • Annals of Surgical Oncology
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Regular and Young Investigator Award Abstracts
  • Cancer Research

Best Publications

  • Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

    Christopher L. Corless;Karla V. Ballman;Cristina R. Antonescu;Violetta Kolesnikova

  • Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non-small cell lung cancer patients

    Tullia C. Bruno;Peggy J. Ebner;Brandon L. Moore;Olivia G. Squalls

  • ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets

    Yuchun Luo;Katiuscia Dallaglio;Ying Chen;William A. Robinson

  • CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue

    Elizabeth Connick;Teresa Mattila;Joy M. Folkvord;Rick Schlichtemeier

  • Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

    Quisette P. Janssen;Stefan Buettner;Mustafa Suker;Berend R. Beumer

  • Post-discharge venous thromboembolism after cancer surgery: Extending the case for extended prophylaxis

    Ryan P. Merkow;Karl Y. Bilimoria;Karl Y. Bilimoria;Martin D. McCarter;Mark E. Cohen

  • Interim analysis of a prospective phase I/II trial of SBRT for liver metastases

    Brian D. Kavanagh;Tracey E. Schefter;Higinia R. Cardenes;Volker W. Stieber

  • Soft Tissue Sarcoma, Version 1.2021: Featured updates to the NCCN guidelines

    Margaret von Mehren;John M. Kane;Marilyn M. Bui;Edwin Choy

  • Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.

    Ronald P. DeMatteo;Karla V. Ballman;Cristina R. Antonescu;Christopher Corless

  • Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner

    Jason T. White;Eric W. Cross;Matthew A. Burchill;Thomas Danhorn

  • Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence

    Martin D. McCarter;Cristina R. Antonescu;Karla V. Ballman;Robert G. Maki

  • Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.

    Richard P. Tobin;Kimberly R. Jordan;William A. Robinson;William A. Robinson;Dana Davis

  • Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer.

    Sachin Wani;Bashar Qumseya;Shahnaz Sultan

  • Dominance of T-helper 2-type cytokines after severe injury.

    Vivian E. Mack;Martin D. McCarter;Hassan A. Naama;Steve E. Calvano

  • Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection.

    Stephanie M Dillon;Kathryn B Robertson;Samuel C Pan;Samantha Mawhinney

  • Long-term outcome of perianal Paget's disease.

    Martin D. McCarter;Stuart H. Q. Quan;Klaus Busam;Philip P. Paty

  • Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.

    C. Preston Neff;Matthew E. Rhodes;Kathleen L. Arnolds;Colm B. Collins

  • Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial

    Kazuo Koyanagi;Anton J. Bilchik;Sukamal Saha;Roderick R. Turner

  • Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

    Jennifer D. Hintzsche;Nicholas T. Gorden;Carol M. Amato;Jihye Kim;Jihye Kim

  • Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients

    Kimberly R. Jordan;Rodabe N. Amaria;Oscar Ramirez;Eryn B. Callihan

Frequent Co-Authors

Richard D. Schulick
Richard D. Schulick University of Colorado Anschutz Medical Campus
Rene Gonzalez
Rene Gonzalez University of Colorado Anschutz Medical Campus
Cara C. Wilson
Cara C. Wilson University of Colorado Anschutz Medical Campus
Sachin Wani
Sachin Wani University of Colorado Anschutz Medical Campus
Wells A. Messersmith
Wells A. Messersmith University of Colorado Boulder
Brent E. Palmer
Brent E. Palmer University of Colorado Denver
Elizabeth Connick
Elizabeth Connick University of Arizona
Virginia F. Borges
Virginia F. Borges University of Colorado Boulder
Karl Y. Bilimoria
Karl Y. Bilimoria Indiana University
David J. Bentrem
David J. Bentrem Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to diverse careers beyond the lab. One growing area is health information management, where professionals ensure accurate medical records and data security. If you’re interested in an affordable path, consider a him degree, which is offered online by many universities for flexible study options.

Medical coding is another in-demand field that offers stable opportunities for Biology and Biochemistry graduates. Learning about medical.coding salary can help you understand the earning potential in this essential profession. With the increasing use of electronic health records, the medical coding job outlook remains very positive, making this a desirable option for those wanting to enter the healthcare industry without direct patient care.

For those passionate about health and nutrition, pursuing a masters in nutrition online can lead to advanced roles in dietetics, wellness coaching, or health education. With the availability of reputable and affordable online programs, students can further specialize while balancing studies with other responsibilities.

Best Scientists Citing Martin D. McCarter

Trending Scientists

Recently Published Articles